 | • レポートコード：MRC2-11QY12376 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は炎症性腸疾患（IBD）のグローバル市場について調査・分析したレポートです。種類別（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物学的薬剤）、免疫調節剤）市場規模、用途別（治療、診断）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別炎症性腸疾患（IBD）の競争状況、市場シェア ・世界の炎症性腸疾患（IBD）市場：種類別市場規模 2015年-2020年（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物学的薬剤）、免疫調節剤） ・世界の炎症性腸疾患（IBD）市場：種類別市場規模予測 2021年-2026年（アミノサリチル酸塩、抗生物質、コルチコステロイド、生物学的療法（生物学的薬剤）、免疫調節剤） ・世界の炎症性腸疾患（IBD）市場：用途別市場規模 2015年-2020年（治療、診断） ・世界の炎症性腸疾患（IBD）市場：用途別市場規模予測 2021年-2026年（治療、診断） ・北米の炎症性腸疾患（IBD）市場分析：米国、カナダ ・ヨーロッパの炎症性腸疾患（IBD）市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの炎症性腸疾患（IBD）市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の炎症性腸疾患（IBD）市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの炎症性腸疾患（IBD）市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bristol-Myers Squibb Company、Baxter International、Johnson & Johnson、Sanofi-Aventis、Abbott Laboratories、Pluristem Therapeutics、Pfizer、AstraZeneca、Cephalon、Amgen ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Inflammatory bowel disease (IBD) is a group of inflammatory conditions of the colon and small intestine. Crohn’s diseaseand ulcerative colitis are the principal types of inflammatory bowel disease. Crohn’s disease affects the small intestine and large intestine, as well as the mouth, esophagus, stomach and the anus, whereas ulcerative colitis primarily affects the colon and the rectum.
Medical treatment of IBD is individualised to each patient. The choice of which drugs to use and by which route to administer them (oral, rectal, injection, infusion) depends on factors including the type, distribution, and severity of the patient’s disease, as well as other historical and biochemical prognostic factors, and patient preferences. For example, mesalazine is more useful in ulcerative colitis than in Crohn’s disease. Generally, depending on the level of severity, IBD may require immunosuppression to control the symptoms, with drugs such as prednisone, TNF inhibitors, azathioprine (Imuran), methotrexate, or 6-mercaptopurine.
Market Analysis and Insights: Global Inflammatory Bowel Disease Market
The global Inflammatory Bowel Disease market size is projected to reach US$ 13200 million by 2026, from US$ 12720 million in 2020, at a CAGR of 3.5%% during 2021-2026.
Global Inflammatory Bowel Disease Scope and Market Size
Inflammatory Bowel Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bristol-Myers Squibb Company
Baxter International
Johnson & Johnson
Sanofi-Aventis
Abbott Laboratories
Pluristem Therapeutics
Pfizer
AstraZeneca
Cephalon
Amgen
Market segment by Type, the product can be split into
Aminosalicylates
Antibiotics
Corticosteroids
Biologic therapies (biological drugs)
Immunomodulators
Market segment by Application, split into
Therapeutic
Diagnostics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inflammatory Bowel Disease Revenue
1.4 Market by Type
1.4.1 Global Inflammatory Bowel Disease Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Aminosalicylates
1.4.3 Antibiotics
1.4.4 Corticosteroids
1.4.5 Biologic therapies (biological drugs)
1.4.6 Immunomodulators
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease Market Share by Application: 2020 VS 2026
1.5.2 Therapeutic
1.5.3 Diagnostics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Market Perspective (2015-2026)
2.2 Global Inflammatory Bowel Disease Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inflammatory Bowel Disease Historic Market Share by Regions (2015-2020)
2.2.3 Inflammatory Bowel Disease Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Inflammatory Bowel Disease Market Growth Strategy
2.3.6 Primary Interviews with Key Inflammatory Bowel Disease Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease Players by Market Size
3.1.1 Global Top Inflammatory Bowel Disease Players by Revenue (2015-2020)
3.1.2 Global Inflammatory Bowel Disease Revenue Market Share by Players (2015-2020)
3.1.3 Global Inflammatory Bowel Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inflammatory Bowel Disease Market Concentration Ratio
3.2.1 Global Inflammatory Bowel Disease Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Revenue in 2019
3.3 Inflammatory Bowel Disease Key Players Head office and Area Served
3.4 Key Players Inflammatory Bowel Disease Product Solution and Service
3.5 Date of Enter into Inflammatory Bowel Disease Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inflammatory Bowel Disease Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Bowel Disease Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Inflammatory Bowel Disease Market Size by Application (2015-2020)
5.2 Global Inflammatory Bowel Disease Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Inflammatory Bowel Disease Market Size (2015-2020)
6.2 Inflammatory Bowel Disease Key Players in North America (2019-2020)
6.3 North America Inflammatory Bowel Disease Market Size by Type (2015-2020)
6.4 North America Inflammatory Bowel Disease Market Size by Application (2015-2020)
7 Europe
7.1 Europe Inflammatory Bowel Disease Market Size (2015-2020)
7.2 Inflammatory Bowel Disease Key Players in Europe (2019-2020)
7.3 Europe Inflammatory Bowel Disease Market Size by Type (2015-2020)
7.4 Europe Inflammatory Bowel Disease Market Size by Application (2015-2020)
8 China
8.1 China Inflammatory Bowel Disease Market Size (2015-2020)
8.2 Inflammatory Bowel Disease Key Players in China (2019-2020)
8.3 China Inflammatory Bowel Disease Market Size by Type (2015-2020)
8.4 China Inflammatory Bowel Disease Market Size by Application (2015-2020)
9 Japan
9.1 Japan Inflammatory Bowel Disease Market Size (2015-2020)
9.2 Inflammatory Bowel Disease Key Players in Japan (2019-2020)
9.3 Japan Inflammatory Bowel Disease Market Size by Type (2015-2020)
9.4 Japan Inflammatory Bowel Disease Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Inflammatory Bowel Disease Market Size (2015-2020)
10.2 Inflammatory Bowel Disease Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inflammatory Bowel Disease Market Size by Type (2015-2020)
10.4 Southeast Asia Inflammatory Bowel Disease Market Size by Application (2015-2020)
11 India
11.1 India Inflammatory Bowel Disease Market Size (2015-2020)
11.2 Inflammatory Bowel Disease Key Players in India (2019-2020)
11.3 India Inflammatory Bowel Disease Market Size by Type (2015-2020)
11.4 India Inflammatory Bowel Disease Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Inflammatory Bowel Disease Market Size (2015-2020)
12.2 Inflammatory Bowel Disease Key Players in Central & South America (2019-2020)
12.3 Central & South America Inflammatory Bowel Disease Market Size by Type (2015-2020)
12.4 Central & South America Inflammatory Bowel Disease Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bristol-Myers Squibb Company
13.1.1 Bristol-Myers Squibb Company Company Details
13.1.2 Bristol-Myers Squibb Company Business Overview
13.1.3 Bristol-Myers Squibb Company Inflammatory Bowel Disease Introduction
13.1.4 Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2015-2020))
13.1.5 Bristol-Myers Squibb Company Recent Development
13.2 Baxter International
13.2.1 Baxter International Company Details
13.2.2 Baxter International Business Overview
13.2.3 Baxter International Inflammatory Bowel Disease Introduction
13.2.4 Baxter International Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.2.5 Baxter International Recent Development
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Details
13.3.2 Johnson & Johnson Business Overview
13.3.3 Johnson & Johnson Inflammatory Bowel Disease Introduction
13.3.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.3.5 Johnson & Johnson Recent Development
13.4 Sanofi-Aventis
13.4.1 Sanofi-Aventis Company Details
13.4.2 Sanofi-Aventis Business Overview
13.4.3 Sanofi-Aventis Inflammatory Bowel Disease Introduction
13.4.4 Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.4.5 Sanofi-Aventis Recent Development
13.5 Abbott Laboratories
13.5.1 Abbott Laboratories Company Details
13.5.2 Abbott Laboratories Business Overview
13.5.3 Abbott Laboratories Inflammatory Bowel Disease Introduction
13.5.4 Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.5.5 Abbott Laboratories Recent Development
13.6 Pluristem Therapeutics
13.6.1 Pluristem Therapeutics Company Details
13.6.2 Pluristem Therapeutics Business Overview
13.6.3 Pluristem Therapeutics Inflammatory Bowel Disease Introduction
13.6.4 Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.6.5 Pluristem Therapeutics Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview
13.7.3 Pfizer Inflammatory Bowel Disease Introduction
13.7.4 Pfizer Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 AstraZeneca
13.8.1 AstraZeneca Company Details
13.8.2 AstraZeneca Business Overview
13.8.3 AstraZeneca Inflammatory Bowel Disease Introduction
13.8.4 AstraZeneca Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.8.5 AstraZeneca Recent Development
13.9 Cephalon
13.9.1 Cephalon Company Details
13.9.2 Cephalon Business Overview
13.9.3 Cephalon Inflammatory Bowel Disease Introduction
13.9.4 Cephalon Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.9.5 Cephalon Recent Development
13.10 Amgen
13.10.1 Amgen Company Details
13.10.2 Amgen Business Overview
13.10.3 Amgen Inflammatory Bowel Disease Introduction
13.10.4 Amgen Revenue in Inflammatory Bowel Disease Business (2015-2020)
13.10.5 Amgen Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Inflammatory Bowel Disease Key Market Segments
Table 2. Key Players Covered: Ranking by Inflammatory Bowel Disease Revenue
Table 3. Ranking of Global Top Inflammatory Bowel Disease Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Inflammatory Bowel Disease Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Aminosalicylates
Table 6. Key Players of Antibiotics
Table 7. Key Players of Corticosteroids
Table 8. Key Players of Biologic therapies (biological drugs)
Table 9. Key Players of Immunomodulators
Table 10. Global Inflammatory Bowel Disease Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Inflammatory Bowel Disease Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Inflammatory Bowel Disease Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Inflammatory Bowel Disease Market Share by Regions (2015-2020)
Table 14. Global Inflammatory Bowel Disease Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Inflammatory Bowel Disease Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. Inflammatory Bowel Disease Market Growth Strategy
Table 20. Main Points Interviewed from Key Inflammatory Bowel Disease Players
Table 21. Global Inflammatory Bowel Disease Revenue by Players (2015-2020) (Million US$)
Table 22. Global Inflammatory Bowel Disease Market Share by Players (2015-2020)
Table 23. Global Top Inflammatory Bowel Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease as of 2019)
Table 24. Global Inflammatory Bowel Disease by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Inflammatory Bowel Disease Product Solution and Service
Table 27. Date of Enter into Inflammatory Bowel Disease Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 30. Global Inflammatory Bowel Disease Market Size Share by Type (2015-2020)
Table 31. Global Inflammatory Bowel Disease Revenue Market Share by Type (2021-2026)
Table 32. Global Inflammatory Bowel Disease Market Size Share by Application (2015-2020)
Table 33. Global Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 34. Global Inflammatory Bowel Disease Market Size Share by Application (2021-2026)
Table 35. North America Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 36. North America Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 37. North America Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 38. North America Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 39. North America Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 40. North America Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 41. Europe Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 43. Europe Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 44. Europe Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 45. Europe Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 46. Europe Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 47. China Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 48. China Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 49. China Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 50. China Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 51. China Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 52. China Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 53. Japan Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 55. Japan Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 56. Japan Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 57. Japan Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 58. Japan Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 61. Southeast Asia Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 63. Southeast Asia Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 65. India Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 66. India Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 67. India Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 68. India Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 69. India Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 70. India Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 71. Central & South America Key Players Inflammatory Bowel Disease Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players Inflammatory Bowel Disease Market Share (2019-2020)
Table 73. Central & South America Inflammatory Bowel Disease Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America Inflammatory Bowel Disease Market Share by Type (2015-2020)
Table 75. Central & South America Inflammatory Bowel Disease Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America Inflammatory Bowel Disease Market Share by Application (2015-2020)
Table 77. Bristol-Myers Squibb Company Company Details
Table 78. Bristol-Myers Squibb Company Business Overview
Table 79. Bristol-Myers Squibb Company Product
Table 80. Bristol-Myers Squibb Company Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 81. Bristol-Myers Squibb Company Recent Development
Table 82. Baxter International Company Details
Table 83. Baxter International Business Overview
Table 84. Baxter International Product
Table 85. Baxter International Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 86. Baxter International Recent Development
Table 87. Johnson & Johnson Company Details
Table 88. Johnson & Johnson Business Overview
Table 89. Johnson & Johnson Product
Table 90. Johnson & Johnson Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 91. Johnson & Johnson Recent Development
Table 92. Sanofi-Aventis Company Details
Table 93. Sanofi-Aventis Business Overview
Table 94. Sanofi-Aventis Product
Table 95. Sanofi-Aventis Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 96. Sanofi-Aventis Recent Development
Table 97. Abbott Laboratories Company Details
Table 98. Abbott Laboratories Business Overview
Table 99. Abbott Laboratories Product
Table 100. Abbott Laboratories Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 101. Abbott Laboratories Recent Development
Table 102. Pluristem Therapeutics Company Details
Table 103. Pluristem Therapeutics Business Overview
Table 104. Pluristem Therapeutics Product
Table 105. Pluristem Therapeutics Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 106. Pluristem Therapeutics Recent Development
Table 107. Pfizer Company Details
Table 108. Pfizer Business Overview
Table 109. Pfizer Product
Table 110. Pfizer Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 111. Pfizer Recent Development
Table 112. AstraZeneca Business Overview
Table 113. AstraZeneca Product
Table 114. AstraZeneca Company Details
Table 115. AstraZeneca Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 116. AstraZeneca Recent Development
Table 117. Cephalon Company Details
Table 118. Cephalon Business Overview
Table 119. Cephalon Product
Table 120. Cephalon Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 121. Cephalon Recent Development
Table 122. Amgen Company Details
Table 123. Amgen Business Overview
Table 124. Amgen Product
Table 125. Amgen Revenue in Inflammatory Bowel Disease Business (2015-2020) (Million US$)
Table 126. Amgen Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease Market Share by Type: 2020 VS 2026
Figure 2. Aminosalicylates Features
Figure 3. Antibiotics Features
Figure 4. Corticosteroids Features
Figure 5. Biologic therapies (biological drugs) Features
Figure 6. Immunomodulators Features
Figure 7. Global Inflammatory Bowel Disease Market Share by Application: 2020 VS 2026
Figure 8. Therapeutic Case Studies
Figure 9. Diagnostics Case Studies
Figure 10. Inflammatory Bowel Disease Report Years Considered
Figure 11. Global Inflammatory Bowel Disease Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Inflammatory Bowel Disease Market Share by Regions: 2020 VS 2026
Figure 13. Global Inflammatory Bowel Disease Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Inflammatory Bowel Disease Market Share by Players in 2019
Figure 16. Global Top Inflammatory Bowel Disease Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Revenue in 2019
Figure 18. North America Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Inflammatory Bowel Disease Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
炎症性腸疾患（IBD）治療の世界市場（～2026年） Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes t…- 炎症性心疾患の世界市場（～2026年） Inflammatory heart disease is mainly caused by various infectious agents which includes viruses, bacteria, fungi and parasites. These infectious agents came into contact with human body via various toxic materials from the environment. Changing lifestyle resulting in higher prevalence of viral and f…
- 短腸症候群（SBS）の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 短腸症候群（SBS）治療薬の世界市場（～2026年） Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 短腸症候群の世界市場（～2026年） Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition…